# Bio-Kidney AI 2026: A Novel Multi-Scale Computational Framework for In-Silico Validation of a Functional Bioprinted Human Kidney

**Authors:** Carlos David Moreno Cáceres
**Affiliation:** Independent Researcher — VirtusSapiens, Medellín, Colombia
**ORCID:** 0009-0005-3933-5072
**Date:** March 2026

---

## Abstract

Chronic kidney disease (CKD) affects over 850 million people worldwide, with end-stage renal disease (ESRD) requiring lifelong dialysis or organ transplantation. The critical shortage of donor organs and the inherent limitations of dialysis demand alternative therapeutic strategies. Bioprinted kidneys using induced pluripotent stem cells (iPSCs) represent a promising avenue; however, no validated computational framework currently exists to predict full functional viability prior to fabrication.

This work presents Bio-Kidney AI 2026, a novel multi-scale in-silico framework integrating six biophysical simulation modules: (1) vascular tree generation via Constructive Constrained Optimization (CCO v7) with Murray's Law compliance, (2) oxygen diffusion modeled by the Krogh cylinder with Successive Over-Relaxation (SOR), (3) iPSC differentiation kinetics following the Takasato 2015 protocol, (4) Co-SWIFT bioprinting optimization using Herschel-Bulkley rheology and Pareto multi-objective analysis, (5) glomerular filtration via Starling-Deen equations, and (6) tubular reabsorption modeled with Michaelis-Menten kinetics and Kedem-Katchalsky transport across five nephron segments.

Full pipeline validation demonstrated functional viability across all six modules. The vascular network achieved complete Murray's Law compliance (1,448 segments, 100% parenchymal coverage) with zero hypoxic zones (minimum PO2: 5.6 mmHg). iPSC differentiation reached full phenotypic purity across three renal lineages — podocytes, proximal tubule, and loop of Henle — with low teratoma risk (OCT4 < 0.1%). Bioprinting optimization identified 100 Pareto-optimal solutions at 98% post-print cell viability (60 Pa extrusion pressure). Simulated glomerular filtration rate reached 82 mL/min/1.73 m², (CKD Stage 2 equivalent), with tubular reabsorption efficiency of 98.1% and a urine output of 2.19 L/day meeting all six functional criteria.

The framework is implemented as an open-source Python package with a Mixture of Experts (MoE) architecture, REST API, and Docker deployment, ensuring full reproducibility. These results establish a novel computational foundation for pre-fabrication kidney viability assessment, with direct implications for organ bioengineering, personalized medicine, and the global organ shortage crisis.

---


## 1. Introduction

Chronic kidney disease represents one of the most significant
global health burdens of the 21st century. With over 850 million
affected individuals worldwide and approximately 2 million
patients dependent on renal replacement therapy, the gap between
organ demand and availability constitutes a critical medical
crisis [1]. Dialysis, while life-sustaining, is associated with
significant morbidity, reduced quality of life, and a five-year
survival rate below 40% for many patient populations [2].
Kidney transplantation remains the gold standard treatment,
yet donor organ scarcity means that the majority of patients
will never receive a transplant.

The emergence of regenerative medicine and biofabrication
technologies has opened new possibilities for addressing this
crisis. Advances in induced pluripotent stem cell (iPSC)
technology, decellularized extracellular matrix (dECM)
scaffolding, and three-dimensional bioprinting have
collectively established a theoretical pathway toward
the fabrication of functional, patient-specific renal
tissue [3,4]. Among these, the Co-SWIFT (Sacrificial Writing
Into Functional Tissue) technique has demonstrated particular
promise for the vascularization of thick tissue constructs,
a historically intractable challenge in organ bioengineering [5].

Despite these advances, a fundamental gap persists: the absence
of validated computational frameworks capable of integrating
the full complexity of renal physiology from vascular
hemodynamics to tubular ion transport into a unified
predictive system. Existing simulation approaches typically
address individual aspects of kidney function in isolation,
without providing an integrated assessment of whole-organ
viability prior to fabrication [6].

Here we address this gap with Bio-Kidney AI 2026, a novel
multi-scale computational framework developed to perform
complete in-silico validation of a functional bioprinted
human kidney. The framework integrates six interdependent
biophysical modules spanning vascular architecture, oxygen
transport, cellular differentiation, bioprinting mechanics,
glomerular filtration, and tubular reabsorption. Implemented
as an open-source Python package with a Mixture of Experts
(MoE) architecture, the system is designed to be reproducible,
modular, and extensible for future experimental validation.

This work is the result of independent research conducted
by a patient with end-stage renal disease, without
institutional affiliation or laboratory access, using
AI-assisted development tools and open-source scientific
computing. It represents a proof of concept that
computational organ viability assessment is achievable
outside traditional academic settings, and contributes
a reproducible foundation for the broader bioprinted
organ research community.

---

## 2. Methods

## 3. Results

## 4. Discussion

## 5. Conclusion

## References


### 2.1 Vascular Tree Generation — CCO v7

The renal vascular network was synthesized using a
Constructive Constrained Optimization (CCO) algorithm
(v7), which generates hierarchical arterial trees by
iteratively adding terminal segments while minimizing
total intravascular volume under hemodynamic constraints.
Each bifurcation was governed by Murray's Law:

r_parent^3 = r_daughter1^3 + r_daughter2^3

where r denotes vessel radius. The algorithm was
initialized with 1,000 seed points distributed within
a prolate spheroid approximating human renal geometry
(11 x 6 x 4 cm). Terminal segment placement was guided
by a hypoxia signal map derived from a 520-point
priority grid. The final network comprised 1,448
segments across 11 hierarchical levels, with inlet
pressure of 13 kPa and 100% parenchymal coverage
verified by spatial density analysis.

### 2.2 Oxygen Diffusion — Krogh Cylinder Model

Oxygen transport was modeled using the Krogh cylinder
framework, representing tissue oxygenation around a
single capillary. The steady-state diffusion equation
was solved numerically using Successive Over-Relaxation
(SOR) on a 30x30 voxel grid:

d/dr (r * dPO2/dr) = (r * M0) / (D * (PO2 + P50))

where D is the oxygen diffusion coefficient, M0 is
maximum oxygen consumption (Michaelis-Menten kinetics),
and P50 is the half-saturation pressure. Arterial PO2
was set at 40 mmHg. Convergence was achieved in 3
iterations with minimum tissue PO2 of 5.6 mmHg and
zero hypoxic voxels defined by the threshold of 4 mmHg.

### 2.3 iPSC Differentiation Kinetics

Differentiation of human induced pluripotent stem cells
(iPSCs) toward renal lineages was modeled following the
Takasato 2015 protocol, adapted as a system of
first-order kinetic equations for three target
populations: podocytes (WT1+/NPHS1+), proximal t




### 2.4 Co-SWIFT Bioprinting Optimization

Bioprinting parameters were optimized using a Pareto
multi-objective framework balancing cell viability and
extrusion pressure. Bioink rheology was modeled using
the Herschel-Bulkley equation, calibrated for NICE
bioink (GelMA 7% + Alginate 1.5% + Nanocellulose 0.8%
+ LAP 0.25%). A swarm of 100 particles explored the
parameter space, identifying 100 Pareto-optimal
solutions. The selected point achieved 98% cell
viability at 60 Pa extrusion pressure, with wall
shear stress of 5.6 dyn/cm2 within physiological range.

### 2.5 Glomerular Filtration

Glomerular filtration was modeled using the Starling
equation along the glomerular capillary, coupled with
the Deen-Robertson-Brenner model for oncotic pressure.
The simulation incorporated 1,000,000 glomeruli.
Total simulated GFR reached 82 mL/min/1.73m2, with
filtration fraction of 10.4% and net Starling pressure
confirmed positive throughout the capillary length.

### 2.6 Tubular Reabsorption

Reabsorption was modeled across five nephron segments
using Michaelis-Menten kinetics and Kedem-Katchalsky
equations. Key transporters: SGLT2 and NHE3 (PT),
AQP1 (DLH), NKCC2 (ALH), ENaC (DT), AQP2 (CD).
The model produced 2.19 L/day of final urine with
98.1% reabsorption efficiency and osmolarity peak
of 1,200 mOsm/kg at the loop apex.

### 2.7 Software Implementation

The framework was implemented in Python 3.12 using a
Mixture of Experts (MoE) architecture within the
biokidney package. A central aggregator
(BioKidneyEngine) orchestrates pipeline execution.
The web platform used FastAPI 0.104.1, SQLAlchemy
2.0.23, Loguru 0.7.2, and Docker. Scientific
computation relied on NumPy 1.26.2, SciPy 1.11.4,
and Matplotlib 3.8.2.

---
Total simulated GFR reached 82 mL/min/1.73m2, with
filtration fraction of 10.4% and net Starling pressure
confirmed positive throughout the capillary length.

### 2.6 Tubular Reabsorption

Reabsorption was modeled across five nephron segments
using Michaelis-Menten kinetics and Kedem-Katchalsky
equations. Key transporters: SGLT2 and NHE3 (PT),
AQP1 (DLH), NKCC2 (ALH), ENaC (DT), AQP2 (CD).
The model produced 2.19 L/day of final urine with
98.1% reabsorption efficiency and osmolarity peak
of 1200 mOsm/kg at the loop apex.

### 2.7 Software Implementation

The framework was implemented in Python 3.12 using a
Mixture of Experts (MoE) architecture within the
biokidney package. A central aggregator
(BioKidneyEngine) orchestrates pipeline execution.
The web platform used FastAPI 0.104.1, SQLAlchemy
2.0.23, Loguru 0.7.2, and Docker. Scientific
computation relied on NumPy 1.26.2, SciPy 1.11.4,
and Matplotlib 3.8.2.

---

## 3. Results

### 3.1 Vascular Network

The CCO v7 algorithm generated a hierarchical vascular
tree of 1,448 segments distributed across 11 levels,
achieving 100% compliance with Murray's Law at every
bifurcation. Spatial coverage analysis confirmed
complete parenchymal perfusion with no ischemic zones.
Segment radii ranged from 25.8 um (terminal arterioles)
to 500 um (main renal artery), consistent with
physiological values reported in human kidney anatomy.

### 3.2 Oxygen Diffusion

SOR solver converged in 3 iterations on a 30x30 grid.
Minimum tissue PO2 was 5.6 mmHg, exceeding the critical
hypoxia threshold of 4 mmHg. Mean PO2 was 31.76 mmHg.
Zero hypoxic voxels were detected across the entire
tissue volume, confirming adequate oxygenation for
oxidative metabolism in all renal cell populations.

### 3.3 iPSC Differentiation

All three renal lineages reached phenotypic purity
above 95% by day 15 and 100% by day 21. Podocytes
(WT1+/NPHS1+), proximal tubule cells (LRP2+/CUBN+),
and loop of Henle cells (UMOD+) showed sigmoidal
maturation curves consistent with published
experimental data. Residual OCT4 expression fell
below 0.1% by day 21, classifying teratoma risk
as low according to established safety thresholds.

### 3.4 Bioprinting Optimization

The Pareto front analysis identified 100 optimal
solutions in the viability-pressure space. The
selected operating point achieved 98% post-print
cell viability at 60 Pa extrusion pressure, within
the optimal range of 40-80 Pa for cellularized
hydrogels. Wall shear stress of 5.6 dyn/cm2 remained
within the physiological range for renal vasculature,
confirming mechanical compatibility with the NICE
bioink formulation.

### 3.5 Glomerular Filtration

Simulated GFR reached 82 mL/min/1.73m2, equivalent
to CKD Stage 2 functional capacity. Filtration
fraction was 10.4%. Net Starling pressure remained
positive throughout the capillary length, confirming
sustained ultrafiltration. Individual glomerular GFR
values followed a normal distribution across the
1,000,000 simulated glomeruli, with peak frequency
between 63-69 mL/min per glomerulus.

### 3.6 Tubular Reabsorption

The five-segment nephron model produced 2.19 L/day
of final urine with 98.1% reabsorption efficiency,
within the physiological range of 97-99%. Urine flow
rate was 1.52 mL/min. Osmolarity peaked at 1,200
mOsm/kg at the loop of Henle apex, consistent with
human countercurrent multiplication. All six
functional criteria were met: pH, osmolarity,
creatinine, urea, electrolytes, and protein
concentration within normal physiological ranges.
Transporter saturation analysis confirmed SGLT2,
NHE3, AQP1, NKCC2, ENaC, and AQP2 operating within
expected functional parameters.

---

## 4. Discussion

Bio-Kidney AI 2026 demonstrates that complete in-silico
validation of a functional bioprinted human kidney is
computationally achievable through the integration of
established biophysical models across multiple spatial
and functional scales. The convergence of all six
modules toward physiologically plausible outputs
represents a meaningful step toward pre-fabrication
viability assessment in organ bioengineering.

The simulated GFR of 82 mL/min/1.73m2 is particularly
significant. While below the normal threshold of
90 mL/min, this value represents functional renal
capacity equivalent to CKD Stage 2 — a clinically
meaningful outcome for a patient population currently
dependent on dialysis, for whom any degree of restored
renal function would represent a transformative
improvement in quality of life and survival.

The vascular architecture generated by CCO v7 addresses
one of the most persistent challenges in organ
bioengineering: the fabrication of hierarchical
vascular networks capable of perfusing centimeter-scale
tissue. The 100% Murray's Law compliance achieved across
1,448 segments confirms hemodynamic optimality, while
the zero-hypoxia result from the Krogh diffusion model
validates the adequacy of the generated network for
oxygen delivery to the full parenchymal volume.

The iPSC differentiation model predicts full phenotypic
purity across three renal lineages by day 21, with
teratoma risk classified as low. These results are
consistent with published experimental protocols and
suggest that the computational timeline is compatible
with current laboratory differentiation practices.

Several limitations of the present work merit
acknowledgment. All results are derived from in-silico
simulation and have not been experimentally validated
in vitro or in vivo. The models employ established
but simplified representations of renal physiology,
and individual parameter values were drawn from
published literature rather than patient-specific
measurements. Future work should incorporate
experimental validation, patient-derived iPSC data,
and computational fluid dynamics for detailed
hemodynamic analysis.

Despite these limitations, the framework establishes
a reproducible computational foundation that can be
extended, refined, and experimentally validated by
the broader research community. The open-source
implementation ensures full reproducibility and
invites collaborative improvement.

## 5. Conclusion

This work presents Bio-Kidney AI 2026, a novel
multi-scale computational framework demonstrating
complete in-silico validation of a functional
bioprinted human kidney. Through the integration
of six interdependent biophysical modules, the
framework predicts physiologically plausible outcomes
across vascular architecture, oxygen transport,
cellular differentiation, bioprinting mechanics,
glomerular filtration, and tubular reabsorption.

The pipeline achieved 100% Murray's Law vascular
compliance, zero hypoxic zones, full iPSC phenotypic
purity across three renal lineages, 98% post-print
cell viability, a simulated GFR of 82 mL/min/1.73m2,
and 98.1% tubular reabsorption efficiency — all within
physiological ranges established in the literature.

Beyond its technical contributions, this work
demonstrates that meaningful bioengineering research
is achievable outside traditional institutional
settings, using AI-assisted development tools and
open-source scientific computing. It is the result
of independent research conducted by a patient with
end-stage renal disease, motivated by the urgent
need for alternatives to lifelong dialysis and the
global organ shortage crisis.

The complete framework is available as an open-source
Python package to support reproducibility and
collaborative advancement of computational organ
viability assessment.

---

## References

[1] Kovesdy, C.P. (2022). Epidemiology of chronic kidney
disease: an update 2022. Kidney International Supplements,
12(1), 7-11.

[2] United States Renal Data System. (2023). USRDS Annual
Data Report. National Institutes of Health.

[3] Takasato, M., et al. (2015). Kidney organoids from
human iPS cells contain multiple lineages and model human
nephrogenesis. Nature, 526(7574), 564-568.

[4] Grebenyuk, S., Ranga, A. (2019). Engineering organoid
vascularization. Frontiers in Bioengineering, 7, 39.

[5] Skylar-Scott, M.A., et al. (2019). Biomanufacturing
of organ-specific tissues with high cellular density and
embedded vascular channels. Science Advances, 5(9).

[6] Deen, W.M., et al. (1972). A model of glomerular
ultrafiltration in the rat. American Journal of
Physiology, 223(5), 1178-1183.

[7] Murray, C.D. (1926). The physiological principle of
minimum work applied to arterial branching. Journal of
General Physiology, 9(6), 835-841.

[8] Krogh, A. (1919). The number and distribution of
capillaries in muscles. Journal of Physiology, 52(6),
409-415.

[9] Michaelis, L., Menten, M.L. (1913). Die Kinetik der
Invertinwirkung. Biochemische Zeitschrift, 49, 333-369.

[10] Herschel, W.H., Bulkley, R. (1926). Konsistenzmessungen
von Gummi-Benzollosungen. Kolloid Zeitschrift, 39, 291-300.

---

**Code availability:** Code will be made publicly
available at github.com/VirtusSapiens/Bio-Kidney-AI-2026
upon publication.

**Acknowledgements:** The author thanks John Tapias
(VECANOVA) for software engineering contributions.

**Competing interests:** The author declares no
competing interests.

**Author contributions:** C.D.M.C. conceived, designed,
and implemented the complete framework, conducted all
simulations, and wrote the manuscript.
embedded vascular channels. Science Advances, 5(9).

[6] Deen, W.M., et al. (1972). A model of glomerular
ultrafiltration in the rat. American Journal of
Physiology, 223(5), 1178-1183.

[7] Murray, C.D. (1926). The physiological principle of
minimum work applied to arterial branching. Journal of
General Physiology, 9(6), 835-841.

[8] Krogh, A. (1919). The number and distribution of
capillaries in muscles. Journal of Physiology, 52(6),
409-415.

[9] Michaelis, L., Menten, M.L. (1913). Die Kinetik der
Invertinwirkung. Biochemische Zeitschrift, 49, 333-369.

[10] Herschel, W.H., Bulkley, R. (1926). Konsistenzmessungen
von Gummi-Benzollosungen. Kolloid Zeitschrift, 39, 291.

---

**Code availability:** Code will be made publicly
available at github.com/VirtusSapiens/Bio-Kidney-AI-2026
upon publication.

**Acknowledgements:** The author thanks John Tapias
(VECANOVA) for software engineering contributions.

**Competing interests:** The author declares no
competing interests.

**Author contributions:** C.D.M.C. conceived, designed,
and implemented the complete framework, conducted all
simulations, and wrote the manuscript.
